HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
Yam Nath Paudel(Monash University Malaysia), Iekhsan Othman(Monash University Malaysia), Katina Aleksovska(Ss. Cyril and Methodius University in Skopje), Marina Koutsodontis Machado Alvim(Universidade Estadual de Campinas (UNICAMP)), Ayanabha Chakraborti(University of Alabama at Birmingham), Yatinesh Kumari(Monash University Malaysia), Mohd. Farooq Shaikh(University of Mumbai), Ángel Aledo‐Serrano
Cited by 318
Related Papers
Current strategies in extending half-lives of therapeutic proteins
|Journal of Controlled Release|2019|285
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
|Cells|2020|257
Mangrove rare actinobacteria: taxonomy, natural compound, and discovery of bioactivity
|Frontiers in Microbiology|2015|178
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling
|European Journal of Pharmacology|2019|175
Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer
|International Journal of Molecular Sciences|2019|166